PF-Atlas › Clinical Trials › NCT07743996

Emotional and Social Experiences of Antifibrotic Therapy Among Idiopathic Pulmonary Fibrosis /Progressive Pulmonary Fibrosis Patients: A Real-World Study

Emotional and Social Experiences of Antifibrotic Therapy Among Idiopathic Pulmon · Not specified

Registry ID
NCT07743996
Phase
Not specified
Status
Completed
Sponsor
Boehringer Ingelheim
Start
2026-08-01
Enrollment
122
Locations
1

About this trial

This is a cross-sectional study that will be conducted across Japan using an online patient-reported outcome questionnaire. This study tries to find out the attitudes toward and experiences of the emotional and/or social impact of side effects associated with antifibrotic (AF) treatment among Japanese patients with Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF), and how are these attitudes associated with patients' individual characteristics.

View NCT07743996 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT07743996 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.